3 recruiting, 1 not yet recruiting. 3 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Idiopathic Inflammatory Myositis (IIM): new trials by email Literature Review of Idiopathic Inflammatory Myositis (IIM) trials Research Report on Idiopathic Inflammatory Myositis (IIM)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases anti-CD19 CAR-T cells - Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE) | Phase 1 | Not yet recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 6 | 2026-12-01 | 2026-09-02 |
| FT839 in Autoimmune Diseases FT839 - ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM) | Phase 1 / Phase 2 | Recruiting | Fate Therapeutics | 446 | 2026-10-01 | 2026-09-02 |
| Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) ULSC (1.5 x 10^8 cells/dose), Placebo (no cells) - Idiopathic Inflammatory Myositis (IIM), DERMATOMYOSITIS OR POLYMYOSITIS | Phase 2 / Phase 3 | Recruiting | Restem, LLC. | 40 | 2026-01-06 | 2026-04-27 |
| A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease FT819, Fludarabine, Cyclophosphamide - Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM) | Phase 1 | Recruiting | Fate Therapeutics | 244 | 2024-03-28 | 2026-05-22 |
Myositis (4) · Lupus Erythematosus, Systemic (3) · Scleroderma, Systemic (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Arthritis, Rheumatoid (2) · Dermatomyositis (2) · Autoimmune Diseases (1) · Lupus Nephritis (1) · Polymyositis (1)
Connective Tissue Diseases (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Immune System Diseases (3) · Arthritis (2) · Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Joint Diseases (2) · Rheumatic Diseases (2) · Skin Diseases, Vascular (2) · Systemic Vasculitis (2)
Bendamustine Hydrochloride (1) · Cyclophosphamide (1) · fludarabine (1) · fludarabine phosphate (1)
Fate Therapeutics (2) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Restem, LLC. (1)
United States (3) · France (2) · Sweden (1) · United Kingdom (1)
Michael Bubb, MD (1)